Pharmacy Policies
These pharmacy policies are applicable to provider-administered drugs covered by TrueCare Mississippi Medicaid.
The below drugs may be reimbursable for properly prepared and submitted provider medical claims.
The following medications are managed under the Medical Benefit at TrueCare. For medications payable through Gainwell Technologies, the Single Pharmacy Benefit Administrator, please visit here.
The policies below are in PDF format. If you do not have Adobe Acrobat Reader, you may download it here.
The policies below are in PDF format. If you do not have Adobe Acrobat Reader, you may download it here.
A
B
C
D
E
F
G
H
I
K
L
M
N
O
P
Q
R
- Radicava (edaravone injection); Radicava ORS (edaravone oral suspension)
- Ranibizumab (Lucentis, Byooviz, Cimerli)
- Reblozyl (luspatercept-aamt)
- Retisert (fluocinolone acetonide)
- Rituximab (Rituxan, Truxima, Ruxience, Riabni)
- Rivfloza (nedosiran)
- Roctavian (valoctocogene roxaparvovec)
- Ryplazim (plasminogen, human-tvmh)
- Rystiggo (rozanolixizumab-noli)
S
- Saphnelo (anifrolumab-fnia)
- Scenesse (afamelanotide)
- Signifor, Signifor LAR (pasireotide)
- Skysona (elivaldogene autotemcel)
- Somatostatin analogs (Injectable; First generation): Sandostatin (octreotide), Sandostatin LAR (octreotide), Somatuline Depot (lanreotide)
- Spinraza (nusinersen)
- Spravato (esketamine)
- Supprelin LA (histrelin acetate)
- Susvimo (ranibizumab)
- Syfovre (pegcetacoplan)
- Sylvant (siltuximab)